Ignite Creation Date:
2024-07-17 @ 11:08 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06466798
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-06-13
Brief Title:
Fourth Ventricular Administration of Immune Checkpoint Inhibitor Nivolumab and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma Ependymoma and Other CNS Malignancies
Sponsor:
David Ilan Sandberg
Organization:
The University of Texas Health Science Center Houston
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-13
First Submit QC Date:
None
Study First Post Date:
2024-06-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-19
Last Update Post Date:
2024-06-20
Last Update Post Date Type:
ACTUAL